Columbia Wanger Asset Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$9.62M Buy
87,833
+8,734
+11% +$872K 0.14% 182
2017
Q3
$7.81M Sell
79,099
-5,853
-7% -$567K 0.12% 184
2017
Q2
$8.6M Sell
84,952
-60,059
-41% -$6.48M 0.12% 188
2017
Q1
$16.8M Buy
145,011
+45,405
+46% +$5.28M 0.24% 159
2016
Q4
$12M Sell
99,606
-28,922
-23% -$3.2M 0.17% 164
2016
Q3
$14.4M Sell
128,528
-3,178
-2% -$366K 0.19% 161
2016
Q2
$16.3M Buy
131,706
+11,435
+10% +$1.38M 0.19% 153
2016
Q1
$13.5M Sell
120,271
-700,051
-85% -$72.7M 0.15% 161
2015
Q4
$89.2M Sell
820,322
-120,285
-13% -$13.8M 0.89% 32
2015
Q3
$93.9M Buy
940,607
+185,857
+25% +$20.2M 0.75% 42
2015
Q2
$86.1M Buy
754,750
+21,244
+3% +$2.58M 0.55% 69
2015
Q1
$76.6M Sell
733,506
-83,040
-10% -$8.85M 0.42% 89
2014
Q4
$98.3M Sell
816,546
-10,193
-1% -$1.34M 0.49% 63
2014
Q3
$121M Sell
826,739
-2,090
-0.3% -$323K 0.56% 47
2014
Q2
$138M Buy
828,829
+117,539
+17% +$20.9M 0.56% 45
2014
Q1
$141M Sell
711,290
-8,244
-1% -$1.56M 0.55% 45
2013
Q4
$137M Sell
719,534
-10,886
-1% -$2.03M 0.52% 55
2013
Q3
$124M Buy
730,420
+100
+0% +$15.5K 0.5% 61
2013
Q2
$111M Buy
+730,320
New +$103M 0.48% 55

Other funds holding CLB

Columbia Wanger Asset Management's CLB Position: Q4 2017 in Review

Columbia Wanger Asset Management increased its Core Laboratories (CLB) stake by 11% in Q4 2017, buying an estimated $872K and bringing the position to 87,833 shares worth $9.62M. The position accounts for 0.14% of the portfolio, ranked #182.

Columbia Wanger Asset Management first reported a position in CLB in Q2 2013 and has held it in 19 quarters since. The position peaked at $141M in Q1 2014. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

  • Columbia Wanger Asset Management held 87,833 shares of Core Laboratories worth $9.62M as of Q4 2017.
  • Columbia Wanger Asset Management bought 8,734 Core Laboratories shares in Q4 2017, an estimated $872K.
  • Core Laboratories made up 0.14% of Columbia Wanger Asset Management's portfolio in Q4 2017, its #182 holding.
  • Columbia Wanger Asset Management first reported a position in Core Laboratories in Q2 2013 and has held it in 19 quarters since.
  • Columbia Wanger Asset Management's Core Laboratories position peaked at $141M in Q1 2014.
  • 356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on Columbia Wanger Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.